Current limitations of SNP data from the public domain for studies of complex disorders: a test for ten candidate genes for obesity and osteoporosis

BMC Genetics

Hong-Wen Deng¹  Robert R Recker²  Peng Xiao²  Sonia Rocha-Sanchez²  Yong-Jun Liu²  Yuan-Yuan Zhang²  Hui Shen²  Lan-Juan Zhao²  Peng-Yuan Liu²  Dong-Hai Xiong²  Ji-Rong Long²  Volodymyr Dvornyk² 

[1] Laboratory of Molecular and Statistical Genetics, College of Life Sciences, Hunan Normal University, Changsha, Hunan 410081, P. R. China;Osteoporosis Research Center and Department of Biomedical Sciences, Creighton University, 601 N. 30th St., Suite 6730, Omaha, NE 68131, USA

关键词: Ethnicity;    Complex diseases;    Osteoporosis;    Obesity;    Polymorphism;    SNP Databases;   

Others  :  1143910
DOI  :  10.1186/1471-2156-5-4

 received in 2003-11-24, accepted in 2004-02-25,  发布年份 2004

【 摘 要 】

Background

Public SNP databases are frequently used to choose SNPs for candidate genes in the association and linkage studies of complex disorders. However, their utility for such studies of diseases with ethnic-dependent background has never been evaluated.

Results

To estimate the accuracy and completeness of SNP public databases, we analyzed the allele frequencies of 41 SNPs in 10 candidate genes for obesity and/or osteoporosis in a large American-Caucasian sample (1,873 individuals from 405 nuclear families) by PCR-invader assay. We compared our results with those from the databases and other published studies. Of the 41 SNPs, 8 were monomorphic in our sample. Twelve were reported for the first time for Caucasians and the other 29 SNPs in our sample essentially confirmed the respective allele frequencies for Caucasians in the databases and previous studies. The comparison of our data with other ethnic groups showed significant differentiation between the three major world ethnic groups at some SNPs (Caucasians and Africans differed at 3 of the 18 shared SNPs, and Caucasians and Asians differed at 13 of the 22 shared SNPs). This genetic differentiation may have an important implication for studying the well-known ethnic differences in the prevalence of obesity and osteoporosis, and complex disorders in general.

Conclusion

A comparative analysis of the SNP data of the candidate genes obtained in the present study, as well as those retrieved from the public domain, suggests that the databases may currently have serious limitations for studying complex disorders with an ethnic-dependent background due to the incomplete and uneven representation of the candidate SNPs in the databases for the major ethnic groups. This conclusion attests to the imperative necessity of large-scale and accurate characterization of these SNPs in different ethnic groups.

【 授权许可】

   
2004 Dvornyk et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Taylor JG, Choi EH, Foster CB, Chanock SJ: Using genetic variation to study human disease. Trends Mol Med 2001, 7:507-512.
• [2]Brookes AJ: The essence of SNPs. Gene 1999, 234:177-186.
• [3]Miller RD, Kwok PY: The birth and death of human single-nucleotide polymorphisms: new experimental evidence and implications for human history and medicine. Hum Mol Genet 2001, 10:2195-2198.
• [4]Gray IC, Campbell DA, Spurr NK: Single nucleotide polymorphisms as tools in human genetics. Hum Mol Genet 2000, 9:2403-2408.
• [5]Lin RCY, Wang XL, Dalziel B, Caterson ID, Morris BJ: Association of obesity, but not diabetes or hypertension, with glucocorticoid receptor N363S variant. Obes Res 2003, 11:802-808.
• [6]Tamura K, Suzuki M, Arakawa H, Tokuyama K, Morikawa A: Linkage and association studies of STAT6 gene polymorphisms and allergic diseases. Int Arch Allergy Immunol 2003, 131:33-38.
• [7]Yamada Y, Ando F, Niino N, Shimokata H: Association of polymorphisms of interleukin-6, osteocalcin, and vitamin D receptor genes, alone or in combination, with bone mineral density in community-dwelling Japanese women and men. J Clin Endocrinol Metab 2003, 88:3372-3378.
• [8]Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES: High-resolution haplotype structure in the human genome. Nat Genet 2001, 29:229-232.
• [9]Jeffreys AJ, Kauppi L, Neumann R: Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex. Nat Genet 2001, 29:217-222.
• [10]Reich DE, Cargill M, Bolk S, Ireland J, Sabeti PC, Richter DJ, Lavery T, Kouyoumjian R, Farhadian SF, Ward R, Lander ES: Linkage disequilibrium in the human genome. Nature 2001, 411:199-204.
• [11]Patil N, Berno AJ, Hinds DA, Barrett WA, Doshi JM, Hacker CR, Kautzer CR, Lee DH, Marjoribanks C, McDonough DP, Nguyen BT, Norris MC, Sheehan JB, Shen N, Stern D, Stokowski RP, Thomas DJ, Trulson MO, Vyas KR, Frazer KA, Fodor SP, Cox DR: Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 2001, 294:1719-1723.
• [12]Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D: The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
• [13]Phillips MS, Lawrence R, Sachidanandam R, Morris AP, Balding DJ, Donaldson MA, Studebaker JF, Ankener WM, Alfisi SV, Kuo FS, Camisa AL, Pazorov V, Scott KE, Carey BJ, Faith J, Katari G, Bhatti HA, Cyr JM, Derohannessian V, Elosua C, Forman AM, Grecco NM, Hock CR, Kuebler JM, Lathrop JA, Mockler MA, Nachtman EP, Restine SL, Varde SA, Hozza MJ, Gelfand CA, Broxholme J, Abecasis GR, Boyce-Jacino MT, Cardon LR: Chromosome-wide distribution of haplotype blocks and the role of recombination hot spots. Nat Genet 2003, 33:382-387.
• [14]Aerts J, Wetzels Y, Cohen N, Aerssens J: Data mining of public SNP databases for the selection of intragenic SNPs. Hum Mutat 2002, 20:162-173.
• [15]Thorisson GA, Stein LD: The SNP Consortium website: past, present and future. Nucleic Acids Res 2003, 31:124-127.
• [16]Hirakawa M, Tanaka T, Hashimoto Y, Kuroda M, Takagi T, Nakamura Y: JSNP: a database of common gene variations in the Japanese population. Nucleic Acids Res 2002, 30:158-162.
• [17]Hirakawa M: HOWDY: an integrated database system for human genome research. Nucleic Acids Res 2002, 30:152-157.
• [18]Marsh S, Kwok P, McLeod HL: SNP databases and pharmacogenetics: great start, but a long way to go. Hum Mutat 2002, 20:174-179.
• [19]Reich DE, Gabriel SB, Altshuler D: Quality and completeness of SNP databases. Nat Genet 2003, 33:457-458.
• [20]Marth G, Yeh R, Minton M, Donaldson R, Li Q, Duan S, Davenport R, Miller RD, Kwok PY: Single-nucleotide polymorphisms in the public domain: how useful are they? Nat Genet 2001, 27:371-372.
• [21]Carlson CS, Eberle MA, Rieder MJ, Smith JD, Kruglyak L, Nickerson DA: Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans. Nat Genet 2003, 33:518-521.
• [22]Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL: Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994, 272:205-211.
• [23]Kopelman PG: Obesity as a medical problem. Nature 2000, 404:635-643.
• [24]Spencer H, Kramer L: NIH consensus conference: Osteoporosis, Factors contributing to osteoporosis. J Nutr 1986, 116:319-322.
• [25]Ray NF, Chan JK, Thamer M, Melton LJ III: Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 1997, 12:24-35.
• [26]Goddard KA, Hopkins PJ, Hall JM, Witte JS: Linkage disequilibrium and allele-frequency distributions for 114 single-nucleotide polymorphisms in five populations. Am J Hum Genet 2000, 66:216-234.
• [27]Liu YZ, Liu YJ, Recker RR, Deng HW: Molecular studies of identification of genes for osteoporosis: the 2002 update. J Endocrinol 2003, 177:147-196.
• [28]Lim SK, Park YS, Park JM, Song YD, Lee EJ, Kim KR, Lee HC, Huh KB: Lack of association between vitamin D receptor genotypes and osteoporosis in Koreans. J Clin Endocrinol Metab 1995, 80:3677-3681.
• [29]Nakajima T, Ota N, Shirai Y, Hata A, Yoshida H, Suzuki T, Hosoi T, Orimo H, Emi M: Ethnic difference in contribution of Sp1 site variation of COLIA1 gene in genetic predisposition to osteoporosis. Calcif Tissue Int 1999, 65:352-353.
• [30]Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA: Prediction of bone density from vitamin D receptor alleles. Nature 1994, 367:284-287.
• [31]Lei SF, Deng FY, Liu XH, Huang QR, Qin Y, Zhou Q, Jiang DK, Li YM, Mo XY, Liu MY, Chen XD, Wu XS, Shen H, Dvornyk V, Zhao L, Recker RR, Deng HW: Polymorphisms of four bone mineral density candidate genes in Chinese populations and the comparison with the other populations of different ethnicity. J Bone Miner Metab 2003, 21:34-42.
• [32]Beavan S, Prentice A, Dibba B, Yan L, Coper C, Ralston SH: Polymorphism of the collagen type I α1 gene and ethnic differences in hip-fracture rates. N Engl J Med 1998, 339:351-352.
• [33]Collins-Schramm HE, Phillips CM, Operario DJ, Lee JS, Weber JL, Hanson RL, Knowler WC, Cooper R, Li H, Seldin MF: Ethnic-difference markers for use in mapping by admixture linkage disequilibrium. Am J Hum Genet 2002, 70:737-750.
• [34]B-Rao C: Sample size considerations in genetic polymorphism studies. Hum Hered 2001, 52:191-200.
• [35]Han KO, Moon IG, Hwang CS, Choi JT, Yoon HK, Min HK, Han IK: Lack of an intronic Sp1 binding-site polymorphism at the collagen type I α1 gene in healthy Korean women. Bone 1999, 24:135-137.
• [36]Dvornyk V, Liu H, Shen H, Lei SF, Zhao L, Huang QR, Qin Y, Jiang DK, Long J, Zhang Y, Gong G, Recker RR, Deng HW: Differentiation of Caucasians and Chinese at bone mass candidate genes: implication for ethnic difference of bone mass. Ann Hum Genet 2003, 67:216-227.
• [37]Yao YG, Watkins WS, Zhang YP: Evolutionary history of the mtDNA 9-bp deletion in Chinese populations and its relevance to the peopling of east and southeast Asia. Hum Genet 2000, 107:504-512.
• [38]Lum JK, Cann RL: mtDNA lineage analyses: origins and migrations of Micronesians and Polynesians. Am J Phys Anthropol 2000, 113:151-168.
• [39]Padyukov L, Hahn-Zoric M, Lau YL, Hanson LA: Different allelic frequencies of several cytokine genes in Hong Kong Chinese and Swedish Caucasians. Genes Immun 2001, 2:280-283.
• [40]Bridges SL Jr, Jenq G, Moran M, Kuffner T, Whitworth WC, McNicholl J: Single-nucleotide polymorphisms in tumor necrosis factor receptor genes: definition of novel haplotypes and racial/ethnic differences. Arthritis Rheum 2002, 46:2045-2050.
• [41]Lamsis F, Flannery GR, White NG, Muratore R, Kaelan C, Mitchell RJ: Alleles and haplotypes of tumor necrosis factor (TNF) α and ß genes in three ethnic populations of Sulawesi Indonesia. Hum Biol 2002, 74:381-396.
• [42]Davis JW, Novotny R, Wasnich RD, Ross PD: Ethnic, anthropometric, and lifestyle associations with regional variations in peak bone mass. Calcif Tissue Int 1999, 65:100-105.
• [43]Colin-Bell A, Adair LS, Popkin BM: Ethnic differences in the association between body mass index and hypertension. Am J Epidemiol 2002, 155:346-353.
• [44]Collins-Schramm HE, Kittles RA, Operario DJ, Weber JL, Criswell LA, Cooper RS, Seldin MF: Markers that discriminate between European and African ancestry show limited variation within Africa. Hum Genet 2002, 111:566-569.
• [45]Kaessmann H, Zollner S, Gustafsson AC, Wiebe V, Laan M, Lundeberg J, Uhlen M, Paabo S: Extensive linkage disequilibrium in small human populations in Eurasia. Am J Hum Genet 2002, 70:673-685.
• [46]Sasaki T, Tahira T, Suzuki A, Higasa K, Kukita Y, Baba S, Hayashi K: Precise estimation of allele frequencies of single-nucleotide polymorphisms by a quantitative SSCP analysis of pooled DNA. Am J Hum Genet 2001, 68:214-218.
• [47]Audi L, Garcia-Ramirez M, Carrascosa A: Genetic determinants of bone mass. Horm Res 1999, 51:105-123.
• [48]O'Connell JR, Weeks DE: PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998, 63:259-266.
• [49]Boehnke M: Allele frequency estimation from data on relatives. Am J Hum Genet 1991, 48:22-25.
• [50]Elashoff JD, Query N: Advisor version 3.0 user's guide. Cork, Ireland, Statistical Solutions Ltd. 1999.
• [51]Weir BS: Genetic Data Analysis 2: Methods for Discrete Population Genetic Data. 2nd edition. Sunderland, MA: Sinauer Associates, Inc.; 1996.
• [52]Lund AM, Jensen BL, Nielsen LA, Skovby F: Dental manifestations of osteogenesis imperfecta and abnormalities of collagen I metabolism. J Craniofac Genet Dev Biol 1998, 18:30-37.
• [53]Martin ER, Lai EH, Gilbert JR, Rogala AR, Afshari AJ, Riley J, Finch KL, Stevens JF, Livak KJ, Slotterbeck BD, Slifer SH, Warren LL, Conneally PM, Schmechel DE, Purvis I, Pericak-Vance MA, Roses AD, Vance JM: SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am J Hum Genet 2000, 67:383-394.
• [54]Garcia-Giralt N, Nogues X, Enjuanes A, Puig J, Mellibovsky L, Bay-Jensen A, Carreras R, Balcells S, Diez-Perez A, Grinberg D: Two new single-nucleotide polymorphisms in the COL1A1 upstream regulatory region and their relationship to bone mineral density. J Bone Miner Res 2002, 17:384-393.
• [55]Curran JE, Lea RA, Rutherford S, Weinstein SR, Griffiths LR: Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer. Int J Cancer 2001, 95:271-275.
• [56]Evangelopoulos D, Alevizaki M, Lekakis J, Cimponeriu A, Papamichael C, Kominakis A, Kalofoutis A, Moutsatsou P: Molecular analysis of the estrogen receptor α gene in men with coronary artery disease: association with disease status. Clin Chim Acta 2003, 331:37-44.
• [57]Willing M, Sowers MR, Aron D, Clark MK, Burns TL, Bunten C, Crutchfield M, D'Agostino D, Jannausch M: Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res 1998, 13:695-705.
• [58]Salmen T, Heikkinen AM, Mahonen A, Kroger H, Komulainen M, Saarikoski S, Honkanen R, Maenpää PH: Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy. J Bone Miner Res 2000, 15:315-321.
• [59]Jurada S, Marc J, Prezelj J, Kocijancic A, Komel R: Codon 325 sequence polymorphism of the estrogen receptor α gene and bone mineral density in postmenopausal women. J Steroid Biochem Mol Biol 2001, 78:15-20.
• [60]Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ: The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 2001, 22:2243-2252.
• [61]Flex A, Gaetani E, Pola R, Santoliquido A, Aloi F, Papaleo P, Dal Lago A, Pola E, Serricchio M, Tondi P, Pola P: The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease. Eur J Vasc Endovasc Surg 2002, 24:264-268.
• [62]Vozarova B, Fernandez-Real JM, Knowler WC, Gallart L, Hanson RL, Gruber JD, Ricart W, Vendrell J, Richart C, Tataranni PA, Wolford JK: The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum Genet 2003, 112:409-413.
• [63]Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M: Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren's syndrome and correlate with the clinical manifestations of the disease. Rheumatology (Oxford) 2001, 40:656-661.
• [64]Thompson DB, Ravussin E, Bennett PH, Bogardus C: Structure and sequence variation at the human leptin receptor gene in lean and obese Pima Indians. Hum Mol Genet 1997, 6:675-679.
• [65]Rosmond R, Chagnon YC, Holm G, Chagnon M, Perusse L, Lindell K, Carlsson B, Bouchard C, Bjorntorp P: Hypertension in obesity and the leptin receptor gene locus. J Clin Endocrinol Metab 2000, 85:3126-3131.
• [66]Langdahl BL, Carstens M, Stenkjær L, Eriksen EF: Polymorphisms in the transforming growth factor ß1 gene and osteoporosis. Bone 2003, 32:297-310.
• [67]Keen RW, Snieder H, Molloy H, Daniels J, Chiano M, Gibson F, Fairbairn L, Smith P, MacGregor AJ, Gewert D, Spector TD: Evidence of association and linkage disequilibrium between a novel polymorphism in the transforming growth factor ß1 gene and hip bone mineral density: a study of female twins. Rheumatology 2001, 40:48-54.
• [68]Tsuchiya N, Kawasaki A, Tsao BP, Komata T, Grossman JM, Tokunaga K: Analysis of the association of HLA-DRB1, TNFα promoter and TNFR2 (TNFRSF1B) polymorphisms with SLE using transmission disequilibrium test. Genes Immun 2001, 2:317-322.
• [69]Wieczorek S, Dahmen N, Jagiello P, Epplen JT, Gencik M: Polymorphisms of the tumor necrosis factor receptors: no association with narcolepsy in German patients. J Mol Med 2003, 81:87-90.
• [70]Kimm SY, Glynn NW, Aston CE, Damcott CM, Poehlman ET, Daniels SR, Ferrell RE: Racial differences in the relation between uncoupling protein genes and resting energy expenditure. Am J Clin Nutr 2002, 75:714-719.
• [71]Dalgaard LT, Sørensen TI, Drivsholm T, Borch-Johnsen K, Andersen T, Hansen T, Pedersen O: A prevalent polymorphism in the promoter of the UCP3 gene and its relationship to body mass index and long term body weight change in the Danish population. J Clin Endocrinol Metab 2001, 86:1398-1402.
• [72]Meirhaeghe A, Amouyel P, Helbecque N, Cottel D, Otabe S, Froguel P, Vasseur F: An uncoupling protein 3 gene polymorphism associated with a lower risk of developing Type II diabetes and with atherogenic lipid profile in a French cohort. Diabetologia 2000, 43:1424-1428.
• [73]Chung WK, Luke A, Cooper RS, Rotini C, Vidal-Puig A, Rosenbaum M, Chua M, Solanes G, Zheng M, Zhao L, LeDuc C, Eisberg A, Chu F, Murphy E, Schreier M, Aronne L, Caprio S, Kahle B, Gordon D, Leal SM, Goldsmith R, Andreu AL, Bruno C, DiMauro S, Leibel RL: Genetic and physiologic analysis of the role of uncoupling protein 3 in human energy homeostasis. Diabetes 1999, 48:1890-1895.
• [74]Lanouette CM, Chagnon YC, Rice T, Perusse L, Muzzin P, Giacobino JP, Gagnon J, Wilmore JH, Leon AS, Skinner JS, Rao DC, Bouchard C: Uncoupling protein 3 gene is associated with body composition changes with training in HERITAGE study. J Appl Physiol 2002, 92:1111-1118.
• [75]Chiu KC, Chuang LM, Yoon C: The vitamin D receptor polymorphism in the translation initiation codon is a risk factor for insulin resistance in glucose tolerant Caucasians. BMC Med Genet 2001, 2:2. BioMed Central Full Text
• [76]Bretherton-Watt D, Given-Wilson R, Mansi JL, Thomas V, Carter N, Colston KW: Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer 2001, 85:171-175.
• [77]Bell NH, Morrison NA, Nguyen TV, Eisman J, Hollis BW: ApaI polymorphisms of the vitamin D receptor predict bone density of the lumbar spine and not racial difference in bone density in young men. J Lab Clin Med 2001, 137:133-140.
• [78]Ferrari SL, Rizzoli R, Slosman DO, Bonjour JP: Do dietary calcium and age explain the controversy surrounding the relationship between bone mineral density and vitamin D receptor gene polymorphisms? J Bone Miner Res 1998, 13:363-370.
• [79]Suarez F, Zeghoud F, Rossignol C, Walrant O, Garabedian M: Association between vitamin D receptor gene polymorphism and sex-dependent growth during the first two years of life. J Clin Endocrinol Metab 1997, 82:2966-2970.
• [80]Taverna MJ, Sola A, Guyot-Argenton C, Pacher N, Bruzzo F, Slama G, Reach G, Selam JL: TaqI polymorphism of the vitamin D receptor and risk of severe diabetic retinopathy. Diabetologia 2002, 45:436-442.
• [81]Tao C, Yu T, Garnett S, Briody J, Knight J, Woodhead H, Cowell CT: Vitamin D receptor alleles predict growth and bone density in girls. Arch Dis Child 1998, 79:488-493.
• [82]Fischer PR, Thacher TD, Pettifor JM, Jorde LB, Eccleshall TR, Feldman D: Vitamin D receptor polymorphisms and nutritional rickets in Nigerian children. J Bone Miner Res 2000, 15:2206-2210.
• [83]Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N, Dahiya R: Polymorphisms of estrogen receptor α gene in endometrial cancer. Biochem Biophys Res Commun 2002, 297:558-564.
• [84]Ongphiphadhanakul B, Chanprasertyothin S, Payattikul P, Saetung S, Piaseu N, Chailurkit L, Chansirikarn S, Puavilai G, Rajatanavin R: Association of a T262C transition in exon 1 of estrogen-receptor-α gene with skeletal responsiveness to estrogen in post-menopausal women. J Endocrinol Invest 2001, 24:749-755.
• [85]Koh JM, Kim DJ, Hong JS, Park JY, Lee KU, Kim SY, Kim GS: Estrogen receptor α gene polymorphisms PvuII and XbaI influence association between leptin receptor gene polymorphism (Gln223Arg) and bone mineral density in young men. Eur J Endocrinol 2002, 147:777-783.
• [86]Han KO, Moon IG, Kang YS, Chung HY, Min HK, Han IK: Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women. J Clin Endocrinol Metab 1997, 82:991-995.
• [87]Kikuchi T, Hashimoto N, Kawasaki T, Uchiyama M: Association of serum low-density lipoprotein metabolism with oestrogen receptor gene polymorphisms in healthy children. Acta Paediatr 2000, 89:42-45.
• [88]Lai IC, Liao DL, Bai YM, Lin CC, Yu SC, Chen JY, Wang YC: Association study of the estrogen receptor polymorphisms with tardive dyskinesia in schizophrenia. Neuropsychobiology 2002, 46:173-175.
• [89]Ongphiphadhanakul B, Rajatanavin R, Chanprasertyothin S, Piaseu N, Chailurkit L, Sirisriro R, Komindr S: Estrogen receptor gene polymorphism is associated with bone mineral density in premenopausal women but not in postmenopausal women. J Endocrinol Invest 1998, 21:487-493.
• [90]Hoshino S, Hosoi T, Miyao M, Shiraki M, Orimo H, Ouchi Y, Inoue S: Identification of a novel polymorphism of estrogen receptor-α gene that is associated with calcium excretion in urine. J Bone Miner Metab 2000, 18:153-157.
• [91]Shibue T, Tsuchiya N, Komata T, Matsushita M, Shiota M, Ohashi J, Wakui M, Matsuta K, Tokunaga K: Tumor necrosis factor α 5'-flanking region, tumor necrosis factor receptor II, and HLA-DRB1 polymorphisms in Japanese patients with rheumatoid arthritis. Arthritis Rheum 2000, 43:753-757.
• [92]Hananantachai H, Patarapotikul J, Looareesuwan S, Ohashi J, Naka I, Tokunaga K: Lack of association of -308A/G TNFA promoter and 196R/M TNFR2 polymorphisms with disease severity in Thai adult malaria patients. Am J Med Genet 2001, 102:391-392.
• [93]Ban Y, Taniyama M, Ban Y: Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. J Clin Endocrinol Metab 2000, 85:4639-4643.
• [94]Zhang H, Tao G, Wu Q, Liu J, Gao Y, Chen R, Leng X: Vitamin D receptor gene polymorphism in postmenopausal women of the Han and Uygur nationalities in China. Chin Med J (Engl) 2000, 113:787-789.
• [95]Huang CM, Wu MC, Wu JY, Tsai FJ: Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus. Lupus 2002, 11:31-34.
• [96]Lee CK, Hong JS, Cho YS, Yoo B, Kim GS, Moon HB: Lack of relationship between vitamin D receptor polymorphism and bone erosion in rheumatoid arthritis. J Korean Med Sci 2001, 16:188-192.
• [97]Ongphiphadhanakul B, Rajatanavin R, Chanprasertyothin S, Chailurkit L, Piaseu N, Teerarungsikul K, Sirisriro R, Komindr S, Puavilai G: Vitamin D receptor gene polymorphism is associated with urinary calcium excretion but not with bone mineral density in postmenopausal women. J Endocrinol Invest 1997, 20:592-596.
• [98]Zhao J, Zhou X, Meng X, Liu G, Xing X, Liu H, Xu L: Polymorphisms of vitamin D receptor gene and its association with bone mineral density and osteocalcin in Chinese. Chin Med J (Engl) 1997, 110:366-371.
• [99]Iki M, Saito Y, Dohi Y, Kajita E, Nishino H, Yonemasu K, Kusaka Y: Greater trunk muscle torque reduces postmenopausal bone loss at the spine independently of age, body size, and vitamin D receptor genotype in Japanese women. Calcif Tissue Int 2002, 71:300-307.